Targeting the immunosuppressive effects of Myc-hyperactivation in high-risk osteosarcoma |
Emory University / Jason Yustein, MD/PhD |
Innovation Grants |
2024 |
Georgia |
Defining how unique properties of the pediatric immune system contribute to poor efficacy of checkpoint blockade in children |
Stanford University / Adrienne Long, MD/PhD |
Young Investigator Grants |
2024 |
California |
Unraveling GABAergic interneuron-like lineage in H3G34-mutant hemispheric high-grade gliomas: their impact on network formation and invasion |
Dana-Farber Cancer Institute / Gustavo Alencastro Veiga Cruzeiro, PhD |
Young Investigator Grants |
2024 |
Massachusetts |
Capitalizing on functional genomics with targeted protein degradation in neuroblastoma |
St. Jude Children’s Research Hospital / Ian Delahunty, PhD |
Young Investigator Grants |
2024 |
Tennessee |
Vaccine-boosted CAR T cell therapy for high risk neuroblastoma |
Children’s Hospital of Philadelphia / Timothy Spear, MD/PhD |
Young Investigator Grants |
2024 |
Pennsylvania |
Improving homing and activity of CAR T cells in pediatric sarcomas |
University of Colorado Denver / Joselyn Cruz Cruz, PhD |
Young Investigator Grants |
2024 |
Colorado |
Development of CAR-T therapy for Ewing sarcoma using zebrafish in vivo models |
Children’s Hospital Los Angeles / James Amatruda, MD/PhD |
Innovation Grants |
2024 |
California |
MYCN-induced molecular clock disruption and metabolic rewiring drive neuroblastoma |
Baylor College of Medicine / Lingzhi Li, PhD |
Young Investigator Grants |
2024 |
Texas |
Understanding the role of CDK8 in protein synthesis for treating MYC-driven medulloblastoma |
University of Colorado Denver / Dong Wang, PhD |
Young Investigator Grants |
2024 |
Colorado |